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PathogenicityInfectious bursal disease virus (IBDV) causes an economically important, immunosuppressive disease in
chickens. There are two serotypes of the virus that contain a bi-segmented double-stranded RNA genome.
In December 2008, the ﬁrst very virulent (vv)IBDV was identiﬁed in California, USA and in 2009 we isolated
reassortant viruses in two different locations. Genome segment A of these reassortants was typical of vvIBDV
serotype 1 but genome segment B was most similar to IBDV serotype 2. The CA-K785 reassortant caused 20%
mortality in chickens but no morbidity or mortality in commercial turkey poults despite being infectious.
There have been previous reports of natural reassortants between vvIBDV and other serotype 1 strains, but
a natural reassortant between IBDV serotypes 1 and 2 has not been described. The apparent reassorting of
California vvIBDV with an endemic serotype 2 virus indicates a common host and suggests vvIBDV may
have entered California earlier than originally thought.infectious bursal disease virus;
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Two serotypes of infectious bursal disease virus (IBDV) have
been identiﬁed. The serotype 1 viruses typically infect chickens and
cause immune suppression in that species (Cosgrove, 1962). Serotype
2 viruses infect several avian species including turkeys but no disease
has been attributed to the viruses belonging to this serotype (Chettle
et al., 1985; McFerran et al., 1980; McNulty et al., 1979). The IBDV are
members of the family Birnaviridae, genus Avibirnavirus. They have
a bi-segmented double-stranded RNA genome. Genome segment A
encodes a polyprotein that is self-cleaved by the viral encoded protease
VP4 to yield this protease and the structural proteins pVP2 and VP3
(Lejal et al., 2000). The pVP2 protein is further processed to yield VP2
a major virion capsid protein. A non-structural protein designated VP5
is encoded by an overlapping reading frame in this genome segment
(Mundt et al., 1995). Genome segment B encodes the RNA directed-
RNA polymerase designated VP1 which complexes with VP3 to initiate
capsid formation (Lombardo et al., 1999).A wide range of IBDV serotype 1 pathotypes exist in nature. They
have been generally classiﬁed into sub-clinical (scIBDV), classic virulent
(cvIBDV) and very virulent (vvIBDV) groups (van den Berg et al.,
2004). The very virulent form of IBDV was ﬁrst identiﬁed in Belgium
during the early 1980s and causes an immunosuppressive disease char-
acterized by high mortality (Chettle et al., 1989; van den Berg et al.,
1991). Phylogenetic analysis indicates the vvIBDV have spread to nearly
all poultry producing countries in the world including the United States
(Eterradossi et al., 1999; Stoute et al., 2009; van den Berg et al., 2000).
Phylogenetic studies indicate that all known vvIBDV are closely related
(van den Berg, 2000) andmolecular studies on the vvIBDV genome seg-
ment B indicate it is phylogenetically distinct from all other IBDV strains
(Eterradossi et al., 1999; Islam et al., 2001).
The phylogenetic origins and population studies on vvIBDV sug-
gest that the expansion of a single virus was initiated by an event
where an endemic IBDV segment A was reassorted with a genome
segment B of unknown origin (Hon et al., 2006). The worldwide
spread of this vvIBDV conﬁrms that the conserved co-evolution of
both genome segments has been favored by the selection for this
phenotype (Islam et al., 2001; Le Nouen et al., 2005; Le Nouen et al.,
2006). In one study, co-evolution of the two genome segments was
observed in approximately 70% of the IBDV isolates examined (Le
Nouen et al., 2006). Although co-evolution of the genome segments
is conserved, reassortant vvIBDVwhere segment A is typical of vvIBDV
and segment B is from a serotype 1 non-vvIBDV have been reported to
occur naturally in regions where these viruses are well established
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occurring reassortant IBDV reported in China were unique compared
to other natural reassortants of this virus because their genome seg-
ment A was from an attenuated vaccine strain and genome seg-
ment B was from a vvIBDV strain (Wei et al., 2006, 2008). This
communication describes the molecular characteristics and patho-
genicity of two reassortant IBDV isolates in the U.S. that contain a
vvIBDV genome segment A and a serotype 2 genome segment B.
This is the ﬁrst report of a natural reassortant between IBDV sero-
types 1 and 2. The phylogenetic origin, population dynamics and
potential host for both serotypes in a country where vvIBDV has
only recently been identiﬁed are discussed.
Results
Molecular characterization of CA-K785 and CA-D495
The RT-PCR ampliﬁed genome segment A from CA-K785 and CA-
D495 was sequenced. The full-length CA-K785 (JF907702) and CA-
D495 (JF907703) genome segment A nucleotide sequences were a
98.6% (3156 bp/3200 bp) match to each other. Of the 44 substitution
mutations observed between the two viruses all but 3 were silent.
The amino acid sequences across the highly variable (hv)VP2 region
of these viruses were identical. Except for one synonymous base
change, the hvVP2 sequence regions of genome segment A from
CA-K785 and CA-D495 were a 99.8% (742 bp/743 bp) match to the
ranch A (rA, GQ221682) and ranch B (rB, GQ221683) vvIBDV strains
from California (Jackwood et al., 2009). When the full-length
CA-K785 and CA-D495 segment A nucleotide sequences were com-
pared to full-length segment A of the type strain vvIBDV, UK661
(NC004178) the viruses were a 98.2% and 97.9% match, respectively.
When compared to the Cu-1 (AF362747) cvIBDV type strain the
matches were 95.6% and 95.3%, respectively. Furthermore, the CA-
K785 and CA-D495 had the A222, I242, I256, I294 and S299 amino
acids typically observed in vvIBDV strains.
Using the real-time RT-PCR assay and probe speciﬁc for vvIBDV
segment A sequences, both the CA-K785 and CA-D495 samples tested
positive as expected (data not shown). When the probe speciﬁc for
genome segment A of non-vvIBDV strains was used, the assays tested
negative. Thus, classic and variant serotype 1 IBDV were not detected
in the samples containing these viruses. The real-time RT-PCR assay
conducted using primers speciﬁc for the hvVP2 encoding region in
segment A of serotype 2 IBDV gave negative results when the CA-
K785 and CA-D495 samples were tested. Thus, no known serotype 2
strains were detected in these bursa samples.
Genome segment B of vvIBDV is highly conserved and required for
their high mortality phenotype (Le Nouen et al., 2006). Sequence
characterization of this genome segment was necessary to conﬁrm a
molecular identiﬁcation of vvIBDV. The full-length genome segment
B nucleotide sequences of CA-K785 (JF907705) and CA-D495
(JF907704) were a 98.2% (2730 bp/2780 bp) match with each other.
When they were compared to the partial segment B sequences of
the California vvIBDV strains rA (GQ221684) and rB (GQ221685)
they were an 88.1% (468 bp/531 bp) match.
Genome segment B sequence comparison and phylogenetic analysis
The genome segment B nucleotide sequences of the CA-K785 and
CA-D495 viruses were not typical of vvIBDV, including the rA and
rB California vvIBDV. Thus, we expanded the sequence comparison
to include genome segment B sequences from vvIBDV and non-
vvIBDV isolated in other parts of the world. Although we sequenced
the full-length genome segment B from CA-K785 and CA-D495 our
phylogenetic analysis was constrained by the sequences available in
GenBank which included nucleotides 312 to 855. The viruses and
their GenBank accession numbers were listed by Le Nouen et al.(2006). Segment B sequences used in the analysis included those
from seven vaccine strains, thirty-eight wild-type strains represent-
ing scIBDV, cvIBDV and vvIBDV, three naturally reassorted strains
from Venezuela and two serotype 2 strains from Europe. The genome
segment B sequence of the vvIBDV isolate NIE/98/009/t (AY099457)
from turkeys (Owoade et al., 2004), the U.S. serotype 2 OH strain
(U30819) and four vaccines strains reportedly used in local California
chicken ﬂocks [D78 (AJ878654), Bursine (AJ878659), Bursine 2
(AJ878655) and Variant E (AJ878676)] were also included. The NJ
and UPGMA phylogenetic analysis yielded identical results so only
the NJ tree is shown (Fig. 1). The analysis indicated that the segment
B nucleotide sequences of CA-K785 and CA-D495 were most closely
related to the serotype 2 strain OH (Fig. 1). The nucleotide sequence
identity across the 312–855 bp region of genome segment B was
94.5% (514 bp/544 bp) when the California reassortants were com-
pared to the European serotype 2 viruses TY89 and 23–82. Compared
to the serotype 2 OH strain from the U.S., there was a 97.8%
(532 bp/544 bp) nucleotide sequence match with CA-K785 and CA-
D495 across this 312–855 bp region. When we compared the full-
length CA-K785 and CA-D495 genome segment B nucleotide se-
quences to the full-length OH (U30819) segment B sequence there
was a 95.1% (2643 bp/2780 bp) and 96.0% (2669 bp/2780 bp) match,
respectively. Although some regions were more conserved than
others, the nucleotide mutations were generally spread across the
entire sequence suggesting a recombination event had not occurred.
The OH serotype 2 strain was isolated in 1981 from turkeys in Ohio
(Jackwood et al., 1982a). Since this is a relatively old strain of IBDV
from a different species, more contemporary IBDV strains from com-
mercial chicken ﬂocks in California were examined to determine if
their genome segment B sequences matched the CA-K785 and
CA-D495 viruses. Partial genome segment B sequences (312–855 bp
region) of the 15 non-vvIBDV strains were determined in this
study (GenBank Accession Numbers HQ441144–HQ441158). The nu-
cleotide B segment sequences of CA-K785 and CA-D495 were not as
closely related to these contemporary California IBDV strains (b94%
nucleotide sequence match) compared to the OH serotype 2 virus
that had a 97.69%match across the same region. The genome segment
B phylogenetic analysis using both NJ (Fig. 2) and UPGMA algorithms
placed the CA-K785 and CA-D495 on the same branch but they were
distant from the 15 California non-vvIBDV and the rA and rB vvIBDV.
Pathogenicity of CA-K785 in chickens
The ability of the CA-K785 reassortant to cause disease in 4-
week-old SPF Leghorn chicks was determined and compared to the
rB vvIBDV, STC cvIBDV and Variant E scIBDV. At 2 days following
challenge all birds in the CA-K785, rB and STC groups became de-
pressed. They had typical signs of clinical infectious bursal disease
that included rufﬂed feathers, diarrhea, pasty vents and a reluctance
to move. No morbidity was observed in the birds challenged with
Variant E or in the non-challenged controls. On day 3 following chal-
lenge 2/10 birds in the CA-K785 group died and 6/10 birds in the rB
group died. By day 4 the remaining birds in the rB challenged group
had died. No additional mortality was observed in the CA-K785 chal-
lenged birds and no mortality was observed in the STC, Variant E or
control groups throughout the remainder of the experiment.
Seven days following challenge, birds that survived were exam-
ined for macroscopic and microscopic lesions (Table 1). At necropsy,
macroscopic lesions were observed in the bursa of all birds that sur-
vived the challenge in groups 1–4 but not in the group 5 controls.
The bursas from birds in groups challenged with CA-K785 and STC
were similar in appearance. They included large edematous bursas
that were yellowish in color and had striations on the serosal sur-
faces. The macroscopic lesions in the rB challenge birds were typical
of a vvIBDV and included large bursas with varying degrees of hemor-
rhage and mottled colored kidneys. Some of the rB challenged birds
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Fig. 1. Phylogenetic analysis of genome segment B from reassortant viruses CA-K785 and CA-D495 with serotype 1 and 2 IBDV from around the world. The Neighbor Joining method
using 1000 bootstrap replicates was used. GenBank accession numbers are followed by the common name of each virus.
100 D.J. Jackwood et al. / Virology 420 (2011) 98–105also had ecchymotic hemorrhages on the mucosal surface at the pro-
ventriculus and gizzard junction. Birds challenged with the Variant E
strain had small and friable bursas without discoloration or hemor-
rhage and macroscopic lesions in other organs were not observed.
The mean bursa/body weight ratios of the birds in groups 1, 3 and 4
were signiﬁcantly lower (pb0.05) when compared to the controls.
Since death was accompanied by varying degrees of post-mortem de-
hydration, body weights of birds that succumbed to the infection in
groups 1 and 2 were not reliable for the calculation of bursa/body
weight ratios.Microscopic lesions were observed in the bursa tissues of birds
from groups 1–4 (Table 1). They included moderate to severe lym-
phocyte necrosis, atrophy of the follicles and follicular depletion of
lymphocytes. Bursa tissues from birds challenged with CA-K785, rB
and STC also had signs of inﬂammation and some congestion in
the stroma. The most severe lesions were observed in the rB vvIBDV
group followed by CA-K785, STC and then the Variant E group. No
signiﬁcant microscopic lesions were observed in the spleen, liver,
kidney and proventriculus of birds challenged with CA-K785, STC
and Variant E. However, birds that were challenged with rB had
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Fig. 2. Phylogenetic analysis of genome segment B from California IBDV isolates. The Neighbor Joining method using 1000 bootstrap replicates was used to compare the California
reassortant viruses CA-K785 and CA-D495 with 15 non-vvIBDV strains, the rA and rB vvIBDV strains and the serotype 2 OH virus. GenBank accession numbers are followed by the
common name of each virus.
Table 1
Pathology of CA-K785 in SPF chickens.
Group IBDV challenge
straina
Mortality Mean bursa/body
wt.±SDb
Histopathologic
lesion scoresc
1 CA-K785 2/10 2.44±0.48A 4,4,4,3,4,4,4,3,4,4
2 rB vvIBDV 10/10 ND 4,4,4,4,4,4,4,4,4,4
3 STC cvIBDV 0/10 2.56±0.12A 3,4,3,4,4,4,3,4,4,4
4 Variant E scIBDV 0/10 2.61±0.30A 3,3,2,2,3,3,3,2,3,3
5 Control 0/10 5.33±0.79B 0,0,1,0,0,0,0,0,0,1
Different superscripted letters indicate statistically signiﬁcant differences among the
group means (pb0.05). ND=not determined.
a Speciﬁc-pathogen-free chickens were challenged with IBDV at 4 weeks of age. Each
bird received 105.0 EID50 in 0.1 ml oral-nasally.
b The mean B-BW ratios±standard deviations were calculated for birds that sur-
vived the challenge. Mean B-BW ratios=bursa wt. (g)/body wt. (g)×1000.
c The severity of the microscopic lesions was graded based on the extent of the lym-
phocyte necrosis, follicular depletion and atrophy. Scores of 0 to 4 were used to indi-
cate relative degree of severity, a score of ‘0’ indicated absence of lesions, and scores
1 to 4 were for b25%, 25 to 50%, 50 to 75% and N75% of follicles affected, respectively.
Individual scores for each bird are reported.
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tonsil tissues. Hemorrhages were observed in the isthmus of the pro-
ventriculus of some birds and varying degrees of lymphoid cell ne-
crosis were observed in the liver and kidneys of most birds in this
group.
The RT-PCR assays for IBDV were used to detect CA-K785, STC and
Variant E in the bursa tissues collected at necropsy and from bursa of
birds that succumbed to the infection. The bursa tissues collected at
necropsy from each group were pooled and all except the control
non-inoculated group were positive in the RT-PCR assays for genome
segments A and B. Bursa tissues from birds that died during the ex-
periment were pooled by group and the day of mortality. Each
bursa pool from birds that died as a result of the infection was also
positive in the RT-PCR assays for both genome segments. All the RT-
PCR products were sequenced across the hvVP2 region of genome
segment A and 722 bp region of genome segment B. The results con-
ﬁrmed the identity of each virus in their respective groups (data not
shown).
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The pathogenicity of the CA-K785 reassortant in 3-week-old tur-
key poults was determined and compared to the rB vvIBDV, and OH
serotype 2 IBDV. Two weeks prior to challenge, a randomly selected
group of 16 poults were bled and found to be negative for IBDV sero-
type 1 and 2 neutralizing antibodies. At 3 weeks of age on the day of
challenge, a second randomly selected group of 10 poults were bled
and also found to be sero-negative for neutralizing antibodies to
both serotypes of IBDV.
Morbidity and mortality were not observed in the non-inoculated
controls or in any of the turkeys inoculated with CA-K785, rB or OH
viruses during the 7 days following inoculation. At necropsy on day
7 post-inoculation, all birds were examined for macroscopic lesions
and none were observed in any organs including the bursa, spleen,
liver, kidney, proventriculus and thymus.
The turkey bursa and spleen tissues were examined for micro-
scopic lesions. There were no microscopic lesions in the spleens of
any bird. Bursa tissues from the control group also appeared normal.
Although there was some mild lymphocytic depletion and atrophy
in 2 bursas, most bursa tissues from the CA-K785 inoculated turkeys
had normal lymphocytic populations in the follicles (histopathologic
lesion scores ranged from 0 to 1). However, a mild interfollicular
edema and inﬂammation was observed in the bursa of most birds
in this group. The turkeys inoculated with the rB vvIBDV had similar
microscopic lesions in their bursa tissues. Turkeys inoculated with
the OH serotype 2 strain had mild interfollicular edema and inﬂam-
mation in their bursa tissues and most had a mild lymphocytic de-
pletion and atrophy in the follicles. Histopathologic lesion scores
for the bursa in this group ranged from 1 to 2. Two bursas had
large pyogranulomatous foci characterized by a central area of necrosis
thatwas surrounded bymultinucleated giant cells often associatedwith
a bacterial infection.
The serotype 1 genome segment A RT-PCR assay for IBDV was
used to detect the CA-K785 reassortant and rB vvIBDV strains in the
turkey bursa tissues collected at necropsy. Bursa tissues from these
two groups were positive in this RT-PCR assay and nucleotide se-
quencing conﬁrmed the identity of each virus. Bursa tissues from tur-
keys inoculated with the serotype 2 OH strain and non-inoculated
controls were negative in the serotype 1 RT-PCR assay. The RT-PCR
assay for the genome segment A of the serotype 2 OH strain was pos-
itive in the turkeys inoculated with that virus and nucleotide se-
quencing conﬁrmed its identity. The serotype 2 RT-PCR assay was
negative when turkey bursa tissues from the rB, CA-K785 and control
non-inoculated groups were tested.
Discussion
This is the ﬁrst description of natural reassorting between sero-
type 1 and 2 IBDV strains. The serotype of IBDV is deﬁned by epitopes
on the surface protein VP2 that is encoded by genome segment A
(Letzel et al., 2007). The hvVP2 nucleotide sequences of CA-K785
and CA-D495 were typical of serotype 1 vvIBDV strains. Genetically
the CA-K785 and CA-D495 reassortants were identical across this
hvVP2 region. Since the hvVP2 sequence is highly variable among
IBDV strains, it is likely that these two isolates are clonal (Le Nouen
et al., 2005; Levin et al., 1999). Across the full-length of the genome
segment A there were 44 substitution mutations (98.6% nucleotide
match) between CA-K785 and CA-D495. Of these mutations all but
3 were silent. Thus, the polyproteins of CA-K785 and CA-D495 were
a 99.7% match to each other and across the hvVP2 region they were
a 99.86% match to other vvIBDV from California suggesting these
viruses are closely related.
The genome segment B of vvIBDV is genetically distinct from all
other strains of IBDV (Hon et al., 2006; Islam et al., 2001). When the
nucleotide sequences of the full-length B genome segments fromCA-K785 and CA-D495 were compared, they had 50 nucleotide differ-
ences (98.2% match). All were silent except 3 giving these viruses a
99.7% amino acid identity across the VP1 protein.
Previous phylogenetic studies on the nucleotide sequence of ge-
nome segment B indicated that results obtained on the 5′ two-thirds
of this molecule were comparable to results observed for the entire
segment B sequence (Le Nouen et al., 2005) and therefore, most Gen-
Bank sequences of the IBDV genome segment B include only this 5′
region (Le Nouen et al., 2006). When the genome segment B se-
quences of CA-K785 and CA-D495 were compared to this 5′ region
of those sequences available in GenBank, they were not characteristic
of vvIBDV, cvIBDV or scIBDV serotype 1 viruses. They were very close-
ly related to the genome segment B of a U.S. serotype 2 IBDV desig-
nated OH. Compared to the full-length VP1 protein encoded by
genome segment B from OH, the CA-K785 and CA-D495 viruses had
a 98.5% and 98.6% amino acid sequence identity, respectively.
To rule out the possibility of a mixed infection of serotype 1 and 2
viruses, real-time RT-PCR assays were conducted. The assay for sero-
type 1 hvVP2 sequences employed speciﬁc serotype 1 primers 743-1
and 743-2 plus a probe that was speciﬁc for either the serotype 1
vvIBDV or serotype 1 non-vvIBDV. This assay only detected the sero-
type 1 vvIBDV genome segment A in the original CA-K785 and CA-
D495 samples. A second set of primers (S2-F and S2-R) designed to
amplify a region of genome segment A was speciﬁc for serotype 2 vi-
ruses and in our real-time RT-PCR assay did not amplify serotype 1
strains. No serotype 2 hvVP2 sequences were detected in the original
bursa tissues containing CA-K785 and CA-D495 using this assay. The
absence of a mixed serotype 1 and 2 virus infection was also demon-
strated when bursa tissues from the CA-K785 infection experiments
in chickens and turkeys were examined in the real-time RT-PCR as-
says. Only vvIBDV serotype 1 hvVP2 sequences were detected.
The CA-K785 reassortant was from a commercial layer chicken
ﬂock and CA-D495 originated from a backyard ﬂock of mixed breed
poultry which was approximately 64 km from the commercial layer
ﬂock. For these viruses to exist in nature, a common host and cell tro-
pism must exist for vvIBDV and serotype 2 IBDV. Antibodies to sero-
type 2 viruses have been found in commercial chicken ﬂocks but
there are no reports of these viruses being isolated from chickens
(Jackwood et al., 1985; Jackwood and Saif, 1983). Furthermore, it
has been reported that serotype 2 viruses do not replicate in chicken
lymphoid cells but they have been isolated from the bursa tissue and
the respiratory tract of turkeys (Chettle et al., 1985; Jackwood et al.,
1982b; McNulty et al., 1979; Nieper and Muller, 1996). The pathoge-
nicity of vvIBDV for other poultry and avian species has not been
thoroughly investigated but vvIBDV strains have been isolated from
turkeys (Owoade et al., 2004; Razmyar and Peighambari, 2009), mi-
gratory aquatic fowl (Jeon et al., 2008), and several other sedentary
avian species (Jeon et al., 2008; Kasanga et al., 2008). The cell tropism
of vvIBDV in these species has not been reported. The higher viru-
lence of the vvIBDV compared to cvIBDV and scIBDV may allow
them to infect a wider variety of avian species and thus, increase
the likelihood that vvIBDV strains will encounter serotype 2 viruses.
Serologic studies have shown that serotype 2 viruses are commonly
found in California turkeys (Chin et al., 1984) and are more common
than serotype 1 viruses in free-living wild avian species (Ogawa et al.,
1998). It is possible that the backyard ﬂock where CA-D495 originat-
ed provided a unique opportunity for reassorting of the vvIBDV and
serotype 2 genomes.
Studies on serotype 1/serotype 2 reassortant viruses generated using
reverse genetics indicate that viruseswith a serotype 1 genome segment
A and serotype 2 genome segment B can infect chicken lymphocytes in
vivo but reassortants with a serotype 2 segment A and serotype 1 seg-
ment B did not (Zierenberg et al., 2004). Although it might be possible
for a serotype 1 non-vvIBDV (cvIBDV or scIBDV) reassortantwith a sero-
type 2 genome segment B to exist naturally, the 15 serotype 1 non-
vvIBDV strains we identiﬁed in commercial and backyard California
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ment B sequences that were not related to serotype 2 viruses
(Fig. 2). Furthermore, other studies on the molecular epidemiology
of IBDV genome segments A and B have not found naturally occur-
ring serotype 1 cvIBDV and scIBDV strains with a serotype 2 genome
segment B (Hon et al., 2006; LeNouen et al., 2006) . Together, these data
suggest that the genome segment B in the CA-K785 and CA-D495 virus-
es camedirectly froma serotype 2 virus and not froma serotype 1 strain
endemic to California.
The vvIBDV typically cause very high mortality in SPF chickens
(van den Berg et al., 2004). In our previous studies with the rA and
rB vvIBDV from California, these viruses caused 90–100% mortality
in 4-week-old SPF chicks (Jackwood et al., 2009). We again observed
100% mortality in the 4-week-old SPF chicks inoculated with rB
vvIBDV in this study. Comparatively, the CA-K785 reassortant only
caused 20% mortality in these 4-week-old SPF chicks. This is similar
to the reduced virulence seen with a vvIBDV reassortant from Vene-
zuela (Le Nouen et al., 2006). When the same dose of rB and CA-
K785 was administered to 3-week-old turkey poults, we did not ob-
serve any morbidity or mortality. Although these turkeys were
obtained from a commercial source, they were free of antibodies to
both serotypes of IBDV prior to inoculation. We also did not observed
macroscopic lesions in organ tissues at 7 days post-inoculation and
only minor histopathologic lesions were observed in the bursa tissues
of these turkeys. The data suggest that the rB vvIBDV and the CA-
K785 reassorted virus are not pathogenic in turkey poults. Historical-
ly, the serotype 1 and 2 IBDV have not caused disease in turkeys
(Giambrone et al., 1978; Jackwood et al., 1982a). Although recent
isolates of vvIBDV have not been examined using a controlled chal-
lenge experiment in turkeys, vvIBDV has been isolated from 6 to
8 week old commercial turkey ﬂocks with unexpectedly high mor-
tality (Owoade et al., 2004). Our data demonstrate that, the rB
vvIBDV which is highly pathogenic in chickens, is not pathogenic
in turkeys. Furthermore, the vvIBDV reassortant virus CA-K785
with a serotype 2 genome segment B was also not pathogenic in tur-
keys. These viruses infected the turkeys in our study as evidenced by
positive RT-PCR assays and thus turkeys could act as an asymptom-
atic reservoir for IBDV. Since the virulence of vvIBDV varied in differ-
ent genetic lines of chickens (van den Berg et al., 2004), it is possible
that the vvIBDV and viruses like the CA-K785 reassortant could be
pathogenic in different genetic lines of domestic and wild turkeys.
The presence of serotype 1 genome segment A and serotype 2 genome
segment B reassortant viruses in California also suggests a serotype 2
genome segment A and serotype 1 genome segment B reassortant
may emerge. Although the serotype 2 segment A/serotype 1 segment
B virus created using reverse genetics was unable to replicate in
chickens, it was not tested in turkeys (Zierenberg et al., 2004). The
pathogenicity of such a reassortant for turkeys would need to be ex-
amined but reassorting of genome segments among IBDV serotypes
might eventually lead to a strain that is pathogenic in a species other
than the chicken.
The ﬁrst samples containing vvIBDV were submitted to the CAHFS
Laboratory System in December of 2008. Samples containing the CA-
K785 reassortant virus were submitted 5 months later in May of
2009. If the ﬁrst detection of vvIBDV in December 2008 coincided
with the initial introduction of vvIBDV in the U.S., it seems unlikely
that reassortants would be detected 5 months later because studies
have shown that there is a strong co-evolution of vvIBDV genome
segments A and B (Le Nouen et al., 2006). Studies on the time of
emergence of the most recent common ancestor (TMRCA) suggest
that the vvIBDV emerged in the 1980s following the reassorting of
an IBDV genome segment A, which emerged approximately 20 years
earlier, with a genome segment B from an unidentiﬁed reservoir
(Hon et al., 2006). These studies suggest that the California vvIBDV
may not have had sufﬁcient time to reassort with a serotype 2 IBDV
in California.It is possible that vvIBDV were introduced in California much ear-
lier than their initial detection. Our preliminary data indicate that ma-
ternal immunity and competition with endemic viruses may reduce
the mortality caused by vvIBDV in the U.S. layer and broiler chicken
ﬂocks (Jackwood, 2011). Without routine surveys for vvIBDV in
these commercial poultry ﬂocks, it is possible that the disease went
unrecognized until the right combination of vvIBDV, environment
and a fully susceptible host resulted in an acute high mortality dis-
ease. The presence of reassortant vvIBDV in commercial layer and
backyard chicken ﬂocks in California supports the theory that vvIBDV
strains have been in this region longer than the initial December 2008
isolation would suggest.
It is also possible that these reassorted viruses and vvIBDV were
coincidentally introduced into California chicken ﬂocks at about the
same time. Compared to other vvIBDV, the hvVP2 sequences of the
reassorted viruses CA-K785 and CA-D495 are phylogenetically most
closely related to the rA and rB vvIBDV from California, suggesting
that these viruses evolved in the same geographic location. That
geographic location may have been California but it is possible
that they co-evolved in another country and were introduced in
the U.S. at approximately the same time.
In conclusion, the CA-K785 and CA-D495 isolates contain a sero-
type 1 vvIBDV genome segment A and a genome segment B from se-
rotype 2 IBDV. The viruses were closely related genetically and the
sequences of their full-length genome segments A and B indicated
they were true reassortants and had not recombined to obtain only
partial serotype 1 and 2 sequences. The CA-K785 isolate was patho-
genic in 4 week-old SPF chickens but not in 3-week-old turkeys. Vir-
ulence of the CA-K785 reassortant for chickens was lower than
typically seen for non-reassorted vvIBDV. The CA-K785 reassortant
and rB vvIBDV were able to infect 3-week-old turkeys but they
were not pathogenic in these birds. The data suggest that the reas-
sorted viruses either entered the U.S. at about the same time vvIBDV
strains were ﬁrst detected in that same region of California or vvIBDV
have been replicating and spreading among commercial and back-
yard poultry ﬂocks in California longer than the initial isolation of
these viruses would suggest. The data reafﬁrm that molecular identi-
ﬁcation of vvIBDV from disease outbreaks requires sequence analysis
of both genome segments. If the U.S. is going to control or at least
contain vvIBDV in California, routine surveys for these viruses in com-
mercial and backyard poultry ﬂocks will be essential.Materials and methods
Viruses
The CA-K785 isolate was identiﬁed in commercially reared layer
chickens submitted to the California Animal Health and Food Safety
(CAHFS) Laboratory System in May 2009. The ﬂock of origin was
4 weeks old and birds submitted to the laboratory were stunted with
rufﬂed feathers, signs of dehydration and blood stained vents. The
ﬂock was vaccinated for Newcastle disease, avian infectious bronchitis
and infectious bursal disease (IBD, Bursine live-attenuated vaccine)
4 days prior to being submitted to CAHFS.
The CA-D495 isolate was obtained from two female Araucana
chickens submitted to the CAHFS Laboratory System after they died
acutely in October 2009. These birds came from a backyard ﬂock of
19 chickens consisting of several breeds and an undetermined num-
ber of pigeons. It was located about 64 km from the commercial
layer ﬂock that yielded CA-K785. Both birds were approximately
6 months old and had not been vaccinated for IBD. The chicks were
purchased in April 2009 from a supplier located in California but geo-
graphically distant from any commercial poultry. The two birds had
congested and edematous lungs, enlarged spleens and one bird had
petechial hemorrhages on the serosal surfaces of the small intestine.
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Fifteen IBDV strains from commercial chicken farms in California
were isolated between 2002 and 2006. A portion of their genome seg-
ment B was sequenced and compared to the CA-K785 and CA-D495
viruses.
Detection and identiﬁcation of IBDV
Bursa tissues from commercial layer, broiler and backyard chick-
en ﬂocks in California were submitted to The Food Animal Health
Research Program at The Ohio Agricultural Research and Develop-
ment Center, The Ohio State University. The seventeen bursa tissue
samples which include the CA-K785 and CA-D495 viruses, were ho-
mogenized in TNE buffer (10 mM Tris–HCL, pH 8.0, 100 mM NaCl,
1 mM ethylene diamine tetra acetic acid) and examined for IBDV ge-
nomic RNA using a reverse transcriptase-polymerase chain reaction
(RT-PCR) assay.
The bursa homogenates were extracted using a standard Trizol
procedure (Jackwood et al., 2008). Using a GenAmp RNA PCR kit
(Applied Biosystems, Roche Molecular Systems, Inc., Branchburg,
New Jersey) portions of genome segments A and B were ampliﬁed.
A 743-bp segment of the highly variable region of VP2 (hvVP2)
from nucleotides 737 to 1479 was ampliﬁed using primers 743-1 (5′-
GCCCAGAGTCTACACCAT-3′) and 743-2 (5′-CCCGGATTATGTCTTTGA-
3′) (Jackwood and Sommer-Wagner, 2005). These primers used for
both RT and PCR are located in a conserved sequence region and will
amplify this portion of genome segment A from all serotype 1 IBDV
strains including vvIBDV and non-vvIBDV. They do not amplify genome
segment A from serotype 2 viruses. The RT-PCR conditions and incuba-
tion times for amplifying hvVP2 of serotype 1 IBDV were previously
described (Jackwood et al., 2008).
To amplify the hvVP2 region of serotype 2 IBDV, primers S2-F
(5′-AAGTTGATGGCCACGTGCG-3′) and S2-R (5′-CTCGGATTATGTCCT-
TAAAACC-3′) were used in a real-time RT-PCR assay that was similar
to that previously described (Jackwood et al., 2008) except the
annealing temperature was increased to 57 °C. These primers were
used in both the RT and PCR conducted using a one-step SYBR
Green RNA-to-CT real-time RT-PCR kit (Applied Biosystems, Foster
City, CA). They amplify a 778 bp region of the serotype 2 VP2 gene
from nucleotide 686 to 1463. They did not amplify genome segment
A of serotype 1 rB vvIBDV, STC cvIBDV and Variant E scIBDV. The
viruses CA-K785 and CA-D495 were negative in this assay.
A portion of genome segment B was ampliﬁed using primers
B-168AF (5′-CATAAAGCCTACAGCTGGAC-3′) and B-889R (5′-GTCCACT-
TGATGACTTGAGG-3′) and reaction conditions previously described
(Jackwood et al., 2009). The B-168A and B-889 primers were used in
both the RT and PCR and amplify a 722 bp region of genome segment
B starting at nucleotide 168 and ending at 889. These primers are located
in a relatively conserved sequence region and under the conditions used
in this study they amplify this portion of genome segment B from both
serotypes of IBDV.
A real-time RT-PCR assay was used to detect segment A genetic
material of serotype 1 IBDV strains (Jackwood and Sommer-Wagner,
2011). Brieﬂy, a 1.0 μl volume of RNA extracted from the samples
containing the CA-K785 and CA-D495 isolates was used for the
assay. Primers 743-1 and 743-2 were used to amplify the highly var-
iable sequence in the VP2 gene from serotype 1 viruses and two Taq-
Man probes (Applied Biosystems, Foster City, CA) were used to
detect the RT-PCR products. One probe was speciﬁc for non-vvIBDV
viruses that are endemic to California (VIC-5′-CAGCCAACATT-
GATGC-3′) and the other probe was speciﬁc for vvIBDV (FAM-5′-
CTCAGCTAATATCGATGC-3′). The reactions were conducted using a
real-time RT-PCR assay kit (AgPath-ID, Ambion, Inc., Austin, TX).
The RT was conducted at 48 °C for 10 min followed by a 95 °C dena-
turation for 10 min and then forty cycles of PCR at 95 °C for 15 s,58 °C for 90 s and 72 °C for 90 s in a Roche LightCycler 480 instru-
ment (Roche Diagnostics Corp., Indianapolis, IN). Control samples
used in all real-time RT-PCR assays included the OH serotype 2
virus, rB vvIBDV, STC cvIBDV and Variant E scIBDV. Nucleic acid
extracted from the bursa of non-infected SPF chicks was used as a
negative control.
Nucleotide sequencing and analysis
Full-length genome segment A and B sequences were determined
for the CA-K785 and CA-D495 viruses using primers and procedures
previously described (Jackwood et al., 2008). The positive RT-PCR
samples were prepared for sequence analysis using a Wizard SV Gel
and PCR Clean-Up System (Promega Corp., Madison, WI). The cleaned
RT-PCR samples were sent to the University of Wisconsin, Biotechnol-
ogy Center, DNA Sequence Laboratory (Madison, WI) for cycle se-
quencing. Nucleotide sequence results were downloaded using
Chromas (Technelysium Pty. Ltd., Queensland, Australia). Sequence
analysis and Clustal W alignments were conducted using Accelrys
Gene v2.5 (Accelrys, San Diego, CA). Phylogenetic analysis was con-
ducted using MEGA version 4 software (Tamura et al., 2007). Phylo-
genetic trees were prepared using the unweighted pair-group
methods using arithmetic averages (UPGMA) and Neighbor-Joining
(NJ) distance methods each with 1000 bootstrap replicates.
Pathogenicity in chickens and turkeys
The pathogenicity of the CA-K785 virus was examined in 4 week-
old speciﬁc-pathogen-free (SPF) chickens (Charles River Laboratories,
North Franklin, CT) and 3 week-old large white turkey poults from a
local commercial hatchery that certiﬁed they were free ofMycoplasma,
Salmonella and avian inﬂuenza. The birds were housed in Horsfall
isolation units and given feed and water ad libitum.
The SPF chickens were allotted into 5 groups containing 10 birds
each. Birds in each group except the control were inoculated oral-
nasally with 105 mean egg infectious doses (EID50) as previously de-
scribed (Jackwood et al., 2009). The EID50 titers were determined in
9-day-old embryonated chicken eggs inoculated via the chorioallan-
toic membrane (CAM) route with a 0.1 ml volume of bursa homog-
enate (Jackwood et al., 2009). Birds in group 1 were inoculated
with the CA-K785 virus, group 2 received the vvIBDV isolate desig-
nated ranch B (rB), group 3 were inoculated with the STC classic iso-
late, group 4 received the Variant E strain and group 5 were non-
inoculated controls. The rB, STC and Variant E strains were used for
comparison because they represent the three IBDV pathogenicity
types: vvIBDV, cvIBDV and scIBDV, respectively (van den Berg
et al., 2004). Birds that survived the challenge were euthanized
7 days after being inoculated and examined for gross lesions. Bursa
and body weights were recorded and the tissues collected for histo-
pathology included the bursa, spleen, liver, kidney, proventriculus,
cecal tonsils and thymus.
Turkey poults were allotted into 4 groups of 8 birds each. At 2
and again at 3-weeks of age, prior to being inoculated, serum samples
from randomly selected poults were collected and examined for anti-
bodies to serotype 1 and 2 IBDV using a virus-neutralization (VN)
assay in cell culture. BGM-70 cells grown in 96-well plates were
used in a constant virus-varying antibody VN assay that employed
the serotype 1 Lukert strain virus and serotype 2 OH virus as antigens
(Dybing and Jackwood, 1998). The same inoculation procedure
used for SPF chickens was used for the turkey poults. Each bird in
the respective groups except the control was inoculated oral-nasally
with 105 EID50 of virus. Turkeys in group 1 were inoculated with
the CA-K785 virus, group 2 received the vvIBDV isolate rB, group 3
were inoculated with the serotype 2 OH isolate and group 4 were non-
inoculated controls. The vvIBDV rB strain and serotype 2 OH strain
were used for comparison because both vvIBDV and serotype 2 strains
105D.J. Jackwood et al. / Virology 420 (2011) 98–105have been reported in turkeys (Chin et al., 1984; McFerran et al., 1980;
Owoade et al., 2004; Razmyar and Peighambari, 2009). Turkeys that
survived the challenge were euthanized 7 days post-inoculation and
examined for gross lesions. Bursa and body weights were recorded
and the tissue collected for histopathology included the bursa, spleen,
liver, kidney, proventriculus, cecal tonsils and thymus.
Bursa tissues from the chickens and turkeys were collected for
molecular detection of the viruses using RT-PCR assays. Detection of
serotype 1 IBDV strains CA-785, rB, STC and Variant E was conducted
using the 743-1 and 743-2 primers. Detection of the OH strain was
conducted using serotype 2 speciﬁc primers S2-F and S2-R.
Histopathology
Tissues collected at necropsy were ﬁxed in 10% neutral buffered
formalin, sectioned at 4 μm and stained using hematoxylin and
eosin. They were examined by light microscopy and bursa tissues
were graded based on the extent of lymphocyte necrosis, follicular
depletion and atrophy. Scores of 0 to 4 were used to indicate relative
degree of severity, a score of ‘0’ indicated absence of lesions, and
scores 1 to 4 were for b25%, 25 to 50%, 50 to 75% and N75% of the fol-
licles affected, respectively.
Statistical analysis
Because IBDV infections in chickens cause atrophy of the bursa,
the bursa and body weights measured at necropsy for chickens
were used to calculate a bursa/body weight ratio (B/BW). These
B/BW ratios were compared for statistical differences using the SAS:
Proc GLM program.
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